A machine learning diagnostic model for Pneumocystis jirovecii pneumonia in patients with severe pneumonia

被引:5
|
作者
Li, Xiaoqian [1 ]
Xiong, Xingyu [2 ]
Liang, Zongan [2 ]
Tang, Yongjiang [2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Crit Care Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Pneumocystis jirovecii pneumonia; Severe pneumonia; Machine learning; Diagnostic model; INFECTIOUS-DISEASES SOCIETY; CARINII-PNEUMONIA; PREVENTION; ADULTS;
D O I
10.1007/s11739-023-03353-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe diagnosis of Pneumocystis jirovecii pneumonia (PCP) in patients presenting with severe pneumonia is challenging and delays in treatment were associated with worse prognosis. This study aimed to develop a rapid, easily available, noninvasive machine learning diagnostic model for PCP among patients with severe pneumonia.MethodsA retrospective study was performed in West China Hospital among consecutive patients with severe pneumonia who had undergone bronchoalveolar lavage for etiological evaluation between October 2010 and April 2021. Factors associated with PCP were identified and four diagnostic models were established using machine learning algorithms including Logistic Regression, eXtreme Gradient Boosting, Random Forest (RF) and LightGBM. The performance of these models were evaluated by the area under the receiver operating characteristic curve (AUC).ResultsUltimately, 704 patients were enrolled and randomly divided into a training set (n = 564) and a testing set (n = 140). Four factors were ultimately selected to establish the model including neutrophil, globulin, & beta;-D-glucan and ground glass opacity. The RF model exhibited the greatest diagnostic performance with an AUC of 0.907. The calibration curve and decision curve analysis also demonstrated its accuracy and applicability.ConclusionsWe constructed a PCP diagnostic model in patients with severe pneumonia using four easily available and noninvasive clinical indicators. With satisfying diagnostic performance and good clinical practicability, this model may help clinicians to make early diagnosis of PCP, reduce the delays of treatment and improve the prognosis among these patients.
引用
收藏
页码:1741 / 1749
页数:9
相关论文
共 50 条
  • [21] Serologic Responses to Pneumocystis Proteins in HIV Patients With and Without Pneumocystis jirovecii Pneumonia
    Gingo, Matthew R.
    Lucht, Lorrie
    Daly, Kieran R.
    Djawe, Kpandja
    Palella, Frank J.
    Abraham, Alison G.
    Bream, Jay H.
    Witt, Mallory D.
    Kingsley, Lawrence A.
    Norris, Karen A.
    Walzer, Peter D.
    Morris, Alison
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 57 (03) : 190 - 196
  • [22] Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Lymphoproliferative Disorders
    Obeid, Karam M.
    Aguilar, Javier
    Szpunar, Susan
    Sharma, Mamta
    del Busto, Ramon
    Al-Katib, Ayad
    Johnson, Leonard B.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (01) : 66 - 69
  • [23] Identification of predictive markers of Pneumocystis jirovecii pneumonia in kidney transplant recipients
    Zhou, Jingrun
    Pan, Huaqin
    Zhang, Jiarui
    Luo, Linjie
    Cao, Yumeng
    Wang, Ling
    Cheng, Zhenshun
    Zhang, Guqin
    TRANSPLANT IMMUNOLOGY, 2024, 85
  • [24] Nomogram for Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Pneumonia Patients Undergoing Oral Glucocorticoid Treatment
    Lang, Qin
    Li, Lijuan
    Zhang, Yue
    He, Xing
    Liu, Yafeng
    Liu, Zhen
    Yan, Haiying
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 755 - 767
  • [25] Clinical characteristics and risk factor analysis of Pneumocystis jirovecii pneumonia in patients with CKD: a machine learning-based approach
    Cai, Xiao-Yu
    Cheng, Yi-Chun
    Ge, Shu-Wang
    Xu, Gang
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (03) : 323 - 338
  • [26] Reversible Cystic Lesions of Pneumocystis jirovecii Pneumonia
    Lu, Ching-Lan
    Hung, Chien-Ching
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (06) : E7 - E8
  • [27] Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults
    Zhou, Shiwei
    Aitken, Samuel L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (02): : 182 - 183
  • [28] Pneumocystis jirovecii Pneumonia in Patients with Solid Malignancies: A Retrospective Study in Two Hospitals
    Jeon, Cheon-Hoo
    Kim, Si-Ho
    Kim, Seulki
    Bae, Moonsuk
    Lee, Su-Jin
    Lim, Seungjin
    PATHOGENS, 2022, 11 (10):
  • [29] Seasonal variation in mortality of Pneumocystis jirovecii pneumonia in HIV-infected patients
    Miller, R. F.
    Evans, H. E. R.
    Copas, A. J.
    Huggett, J. F.
    Edwards, S. G.
    Walzer, P. D.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (07) : 497 - 503
  • [30] Pneumocystis jirovecii pneumonia in AIDS and non-AIDS immunocompromised patients - an update
    Lee, Yuan-Ti
    Chuang, Ming-Lung
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2018, 12 (10): : 824 - 834